Spencer Pharmaceutical Inc.
Save
271
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases. The company specializes in the controlled release of existing therapeutic molecules in the areas of central nervous system, which include Alzheimer and Parkinson diseases, and brain cancer; and patented slow release drug delivery technology for the treatment of type-2 diabetes, arthritis, and other potential applications. It has operations primarily in North America and Europe.
Similar securities
Based on sector and market capitalization
Report issue